Why Complete Dose Availability Matters for Your Journey
Manjaro vs Wegovy: Complete Dose Escalation Journey
When comparing Mounjaro vs Wegovy, understanding the complete dose escalation timeline becomes crucial for treatment continuity. Wegovy requires a mandatory 16-week dose escalation starting at 0.25mg for weeks 1-4, progressing through 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), before reaching the 2.4mg maintenance dose from week 17 onwards. This prescription-only medicine cannot skip doses, making reliable pharmacy supply essential for treatment success.
EverydayMeds stocks every Wegovy dose, eliminating the common problem of patients needing to source different doses from multiple pharmacies. Our Step-Up bundles, such as the Intro Trio covering 0.25mg, 0.5mg, and 1mg doses for £299.99, ensure you have Reliable Supply during the critical early months when side effects are most common and adherence is vital.
Manjaro vs Wegovy Pricing: Value Across All Doses
The cost comparison between Mounjaro vs Wegovy varies significantly across dose ranges, with Wegovy pricing starting at £79.99 for the 0.25mg starter dose (after FIRST40 discount for new customers) and reaching £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles, like the Intro Duo (0.25mg & 0.5mg) at £169.99, provide convenient two-month supply without the complexity of separate orders.
For patients reaching maintenance therapy, the Ultimate Stability Trio offers three months of 2.4mg doses for £649.99, providing supply security during the crucial long-term phase. Returning customers benefit from the DOSE25 discount code applied at checkout, whilst all orders include next-day cold-chain delivery to maintain the medication's efficacy from our GPhC-registered facility #9012878.
Clinical Evidence: Manjaro vs Wegovy Trial Data
The STEP trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events with semaglutide treatment.
Mounjaro's SURMOUNT trials showed different endpoints and populations, making direct comparison inappropriate. Both medications work through appetite regulation, though Mounjaro's dual GIP and GLP-1 mechanism differs from Wegovy's GLP-1-only approach, potentially influencing individual response patterns.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. When injected once weekly, it activates GLP-1 receptors in the brain's appetite control centres, reducing hunger signals and promoting satiety after smaller meals. The medication may also slow gastric emptying, helping you feel fuller for longer periods. This mechanism works alongside a reduced-calorie diet and increased physical activity to support sustainable weight management. Unlike Mounjaro's dual hormone approach, Wegovy focuses specifically on GLP-1 pathways, which some patients may find more suitable depending on their metabolic profile.
Manjaro vs Wegovy: Ordering Process at EverydayMeds
Our streamlined process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Qualified prescribers review your assessment within 3 working days (or 24 hours with express service), determining suitability for either Mounjaro or Wegovy based on clinical factors. Once approved, your chosen medication ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. The process ensures clinical safety whilst providing convenient access to both treatment options. All communications remain confidential through our secure patient portal, with ongoing prescriber support throughout your treatment journey.
Storage Advantages: Wegovy vs Manjaro Practicalities
A key practical difference in the Mounjaro vs Wegovy comparison involves storage flexibility, particularly important for travel or lifestyle considerations. Wegovy maintains stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require initial refrigeration at 2-8°C, but Wegovy's extended ambient storage suits frequent travellers or those with irregular schedules. The FlexTouch pen design provides consistent dose delivery across all strengths from 0.25mg through 2.4mg. This prescription-only medicine arrives in temperature-controlled packaging, with clear storage instructions included in every delivery from our GPhC-registered pharmacy.
Dose Escalation Strategy: Why All Doses Matter
The complete availability of Wegovy doses at EverydayMeds addresses a critical treatment challenge: maintaining therapeutic momentum during escalation phases. Many patients experience supply disruptions when pharmacies stock only certain doses, potentially disrupting the carefully planned titration schedule essential for minimising side effects. Our comprehensive stock levels mean your 0.25mg starter pen leads seamlessly to 0.5mg, then 1mg, 1.7mg, and finally 2.4mg maintenance without pharmacy changes.
This continuity proves particularly valuable during dose transitions, when patients may need to repeat doses if side effects occur. Our Consistency bundles, such as Consistency 0.5mg (×2) for £189.99, allow flexible pacing through escalation phases. The Take-It-Slow bundles accommodate patients requiring extended time at lower doses, ensuring personalised treatment progression rather than rigid adherence to standard timelines.
Long-term Maintenance: Manjaro vs Wegovy Supply Security
Reaching the 2.4mg maintenance dose represents a significant milestone, but long-term success depends on consistent supply availability. EverydayMeds' Ultimate Stability Trio provides three months of 2.4mg Wegovy for £649.99, offering supply security during the crucial maintenance phase when treatment benefits require ongoing support. Our prescription-only medicine supply chain prioritises reliability, with backup stock levels maintaining availability even during manufacturing fluctuations.
The STEP 1 extension trial showed patients regained approximately two-thirds of lost weight within one year of stopping treatment, highlighting the importance of uninterrupted maintenance therapy. Whether choosing Mounjaro or Wegovy, both medications are available from EverydayMeds with the same commitment to supply continuity throughout your weight management journey. Your prescriber can help determine which treatment aligns best with your clinical needs and lifestyle requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
